We're your trusted partner in pharmaceutical science and services
Pharmaprimes fosters continuous learning, collaborative innovation, and leadership to revolutionize the future of pharmaceutical research and development.
Dr. Anas Alshishani, an eminent Jordanian analytical chemist, boasts over two decades of experience in the pharmaceutical industry, with notable tenures at Hikma, Dar Al-Dawa, and Chanelle Pharma.
His contributions to drug quality research are substantial, as evidenced by his H-Index of 7 on Scopus.
Dr. Alshishani's extensive body of scholarly work includes high-impact publications and significant peer-reviewed articles. Holding a Ph.D. in Analytical Chemistry from Universiti Sains Malaysia, his research has focused on pioneering microextraction techniques and the application of green analytical methods, marking him as a leader in his field.
Awarded the USM Fellowship, he has consistently demonstrated academic excellence. In his career, Dr. Alshishani has seamlessly connected academia and industry, imparting knowledge at Zarqa University, Jordan, and enhancing pharmaceutical research and quality as a manager at renowned institutions.
His research on genotoxic impurities and new microextraction methods underscores his dedication to advancing pharmaceutical analysis. A trusted consultant for the Jordan Food and Drug Administration and the Pharmaceutical Research Unit, Dr. Alshishani is adept with LC-MS/MS, ICP-MS, HPLC, UPLC, and GC-MS/MS, specializing in HPLC troubleshooting and impurity detection. His expertise is invaluable to pharmaceutical labs seeking to elevate their quality assurance and analytical standards.
Mohammad Reyahee is an accomplished professional with over 26 years of experience in the pharmaceutical industry. His expertise encompasses the full spectrum of pharmaceutical processes, from R&D to quality control and product lifecycle management. Committed to collaboration and quality, Mohammad leads with a philosophy that every challenge is surmountable through teamwork and innovation.
He is a champion of 'Quality by Design', ensuring products meet high standards for the future without compromising on cost-effectiveness. His technical acumen covers all essential operations, from regulatory compliance to technology transfer and manufacturing process optimization.
In quality management, Mohammad's dedication to excellence is unwavering. He is adept in all facets of QC and QA, ensuring safety and adherence to WHO guidelines. His analytical prowess in data handling and statistical analysis informs continuous improvement and decision-making.
With a strong foundation in GMP, Mohammad excels in root cause investigations and CAPA efficiency evaluations, ensuring products meet rigorous quality benchmarks. His comprehensive understanding of the supply chain ensures customer satisfaction from product demand to delivery, making him a pivotal asset to any pharmaceutical endeavor.
Abd Alrahman Mahli is an esteemed figure in pharmaceutical sciences with a PhD in Pharmacy. His expertise in pharmacology, medical biochemistry, and pharmaceutical biotechnology is profound. He excels in PK/PD studies and the execution of Phase III clinical trials adhering to GCP standards. With a notable specialty in developing biologics and biosimilars, Dr. Abdo has also pioneered sophisticated bioanalytical methods, including PK, ADA, and Nab assays.
In 2018, Dr. Abdo was honored as the first Arab scientist to win Germany's best scientific publication prize, a testament to his impactful research (impact factor 25; Mahli et al. Gut; 2018). As Editor in Chief of “BioTech Arab World,” he focuses on biologics and biosimilars, having successfully published two issues to date.
Additionally, Dr. Abdo contributes to the pharmaceutical field as a member of the scientific committee for AUPAM, influencing the industry's growth in the Arab region. His career is a beacon of scientific dedication, innovation, and leadership in biopharmaceutical research.
Abdulanser Alsharaa received his PhD in analytical chemistry. He is working since 2016 in top international CROs in the Netherlands and Dutch Organization of Applied Scientific Research (TNO). As our experienced bioanalysis development expert, he specializes in creating analytical methods for pharmaceutical clinical and pre-clinical applications. With expertise in obtaining lab accreditation documentation.
Dr. Abdulanser has been leading a chromatography team since 2021. His leadership focuses on supporting companies in developing and validating advanced methods for critical bioanalysis, including multiple compounds, drug cocktails, metabolites and biomarkers.